https://www.reforms-project.org.uk/glossary/ 2026-06-01T16:02:54+00:00 https://www.reforms-project.org.uk/glossary/adverse-event-ae/ 2026-01-15T11:38:45+00:00 https://www.reforms-project.org.uk/glossary/alveolar-rhabdomyosarcoma-arms/ 2026-01-15T11:38:45+00:00 https://www.reforms-project.org.uk/glossary/amore/ 2026-01-15T11:38:45+00:00 https://www.reforms-project.org.uk/glossary/antigen/ 2026-01-15T11:38:45+00:00 https://www.reforms-project.org.uk/glossary/antibody/ 2026-01-15T11:38:45+00:00 https://www.reforms-project.org.uk/glossary/brachytherapy/ 2026-01-15T11:38:45+00:00 https://www.reforms-project.org.uk/glossary/biomarker/ 2026-01-15T11:38:45+00:00 https://www.reforms-project.org.uk/glossary/car-t-cells/ 2026-01-15T11:38:45+00:00 https://www.reforms-project.org.uk/glossary/central-nervous-system-cns/ 2026-01-15T11:38:45+00:00 https://www.reforms-project.org.uk/glossary/chemotherapy/ 2026-01-15T11:38:45+00:00 https://www.reforms-project.org.uk/glossary/children-and-young-people-cyp/ 2026-01-15T11:38:45+00:00 https://www.reforms-project.org.uk/glossary/clinical-advisory-group-cag/ 2026-01-15T11:38:45+00:00 https://www.reforms-project.org.uk/glossary/clinical-benefit-rate-cbr/ 2026-01-15T11:38:45+00:00 https://www.reforms-project.org.uk/glossary/clinical-trial/ 2026-01-15T11:38:45+00:00 https://www.reforms-project.org.uk/glossary/clinical-trial-record-ctr/ 2026-01-15T11:38:45+00:00 https://www.reforms-project.org.uk/glossary/cohort/ 2026-01-15T11:38:45+00:00 https://www.reforms-project.org.uk/glossary/complete-response-cr/ 2026-01-15T11:38:45+00:00 https://www.reforms-project.org.uk/glossary/ctcae/ 2026-01-15T11:38:45+00:00 https://www.reforms-project.org.uk/glossary/disease-control-rate-dcr/ 2026-01-15T11:38:45+00:00 https://www.reforms-project.org.uk/glossary/dose-limiting-toxicity-dlt/ 2026-01-15T11:38:47+00:00 https://www.reforms-project.org.uk/glossary/duration-of-response-dor/ 2026-01-15T11:38:47+00:00 https://www.reforms-project.org.uk/glossary/early-phase-trial/ 2026-01-15T11:38:47+00:00 https://www.reforms-project.org.uk/glossary/embryonal-rhabdomyosarcoma-erms/ 2026-01-15T11:38:47+00:00 https://www.reforms-project.org.uk/glossary/evaluable-for-toxicity-response/ 2026-01-15T11:38:47+00:00 https://www.reforms-project.org.uk/glossary/event-free-survival-efs/ 2026-01-15T11:38:47+00:00 https://www.reforms-project.org.uk/glossary/far-rms/ 2026-01-15T11:38:47+00:00 https://www.reforms-project.org.uk/glossary/featured-study/ 2026-01-15T11:38:47+00:00 https://www.reforms-project.org.uk/glossary/febrile-neutropenia/ 2026-01-15T11:38:47+00:00 https://www.reforms-project.org.uk/glossary/fusion-status/ 2026-01-15T11:38:47+00:00 https://www.reforms-project.org.uk/glossary/histopathology/ 2026-01-15T11:38:47+00:00 https://www.reforms-project.org.uk/glossary/haematopoietic-stem-cell-transplant-hsct/ 2026-01-15T11:38:47+00:00 https://www.reforms-project.org.uk/glossary/immunotherapy/ 2026-01-15T11:38:47+00:00 https://www.reforms-project.org.uk/glossary/inhibitor/ 2026-01-15T11:38:47+00:00 https://www.reforms-project.org.uk/glossary/intravenous-iv/ 2026-01-15T11:38:47+00:00 https://www.reforms-project.org.uk/glossary/lines-of-therapy/ 2026-01-15T11:38:47+00:00 https://www.reforms-project.org.uk/glossary/local-disease/ 2026-01-15T11:38:47+00:00 https://www.reforms-project.org.uk/glossary/maximum-tolerated-dose-mtd/ 2026-01-15T11:38:47+00:00 https://www.reforms-project.org.uk/glossary/measurable-disease/ 2026-01-15T11:38:47+00:00 https://www.reforms-project.org.uk/glossary/metastatic-disease/ 2026-01-15T11:38:47+00:00 https://www.reforms-project.org.uk/glossary/minor-response/ 2026-01-15T11:38:48+00:00 https://www.reforms-project.org.uk/glossary/minors-tool/ 2026-01-15T11:38:48+00:00 https://www.reforms-project.org.uk/glossary/molecular-registry-study-mrs/ 2026-01-15T11:38:48+00:00 https://www.reforms-project.org.uk/glossary/mucositis/ 2026-01-15T11:38:48+00:00 https://www.reforms-project.org.uk/glossary/multi-agent-therapy/ 2026-01-15T11:38:48+00:00 https://www.reforms-project.org.uk/glossary/multiple-arm-trial/ 2026-01-15T11:38:48+00:00 https://www.reforms-project.org.uk/glossary/mutation/ 2026-01-15T11:38:48+00:00 https://www.reforms-project.org.uk/glossary/nausea/ 2026-01-15T11:38:48+00:00 https://www.reforms-project.org.uk/glossary/neutropenia/ 2026-01-15T11:38:48+00:00 https://www.reforms-project.org.uk/glossary/no-evidence-of-disease-ned/ 2026-01-15T11:38:48+00:00 https://www.reforms-project.org.uk/glossary/non-parameningeal-disease/ 2026-01-15T11:38:48+00:00 https://www.reforms-project.org.uk/glossary/not-calculable/ 2026-01-15T11:38:48+00:00 https://www.reforms-project.org.uk/glossary/not-reported-nr/ 2026-01-15T11:38:48+00:00 https://www.reforms-project.org.uk/glossary/novel-therapy/ 2026-01-15T11:38:48+00:00 https://www.reforms-project.org.uk/glossary/overall-survival-os/ 2026-01-15T11:38:48+00:00 https://www.reforms-project.org.uk/glossary/parameningeal-disease/ 2026-01-15T11:38:48+00:00 https://www.reforms-project.org.uk/glossary/partial-response-pr/ 2026-01-15T11:38:48+00:00 https://www.reforms-project.org.uk/glossary/phase-of-a-study/ 2026-01-15T11:38:48+00:00 https://www.reforms-project.org.uk/glossary/precision-guided-therapy/ 2026-01-15T11:38:49+00:00 https://www.reforms-project.org.uk/glossary/progression-free-survival-pfs/ 2026-01-15T11:38:49+00:00 https://www.reforms-project.org.uk/glossary/progressive-disease-pd/ 2026-01-15T11:38:49+00:00 https://www.reforms-project.org.uk/glossary/ppi-parent-group/ 2026-01-15T11:38:49+00:00 https://www.reforms-project.org.uk/glossary/quality-assessment/ 2026-01-15T11:38:49+00:00 https://www.reforms-project.org.uk/glossary/qualitative-research/ 2026-01-15T11:38:49+00:00 https://www.reforms-project.org.uk/glossary/quantitative-research/ 2026-01-15T11:38:49+00:00 https://www.reforms-project.org.uk/glossary/randomised-control-trial-rct/ 2026-01-15T11:38:49+00:00 https://www.reforms-project.org.uk/glossary/recist-criteria/ 2026-01-15T11:38:49+00:00 https://www.reforms-project.org.uk/glossary/refractory-disease/ 2026-01-15T11:38:49+00:00 https://www.reforms-project.org.uk/glossary/regimen/ 2026-01-15T11:38:49+00:00 https://www.reforms-project.org.uk/glossary/relapsed-disease/ 2026-01-15T11:38:49+00:00 https://www.reforms-project.org.uk/glossary/rhabdomyosarcoma-rms/ 2026-01-15T11:38:49+00:00 https://www.reforms-project.org.uk/glossary/risk-of-bias/ 2026-01-15T11:38:49+00:00 https://www.reforms-project.org.uk/glossary/single-agent-therapy/ 2026-01-15T11:38:49+00:00 https://www.reforms-project.org.uk/glossary/single-arm-trial/ 2026-01-15T11:38:49+00:00 https://www.reforms-project.org.uk/glossary/soft-tissue-sarcoma-sts/ 2026-01-15T11:38:49+00:00 https://www.reforms-project.org.uk/glossary/solid-tumours/ 2026-01-15T11:38:49+00:00 https://www.reforms-project.org.uk/glossary/spindle-cell-rhabdomyosarcoma/ 2026-01-15T11:38:49+00:00 https://www.reforms-project.org.uk/glossary/stable-disease-sd/ 2026-01-15T11:38:50+00:00 https://www.reforms-project.org.uk/glossary/systematic-review/ 2026-01-15T11:38:50+00:00 https://www.reforms-project.org.uk/glossary/targeted-therapy/ 2026-01-15T11:38:50+00:00 https://www.reforms-project.org.uk/glossary/thrombocytopenia/ 2026-01-15T11:38:50+00:00 https://www.reforms-project.org.uk/glossary/time-to-progression-ttp/ 2026-01-15T11:38:50+00:00 https://www.reforms-project.org.uk/glossary/treatment-related-adverse-event-trae/ 2026-01-15T11:38:50+00:00 https://www.reforms-project.org.uk/glossary/tumour-mutational-burden/ 2026-01-15T11:38:50+00:00 https://www.reforms-project.org.uk/glossary/undifferentiated-relapse/ 2026-01-15T11:38:50+00:00 https://www.reforms-project.org.uk/glossary/best-overall-response-bor/ 2026-03-31T11:16:31+00:00 https://www.reforms-project.org.uk/glossary/graft-versus-host-disease/ 2026-03-31T11:20:01+00:00 https://www.reforms-project.org.uk/glossary/pharmacokinetics/ 2026-03-31T11:21:28+00:00 https://www.reforms-project.org.uk/glossary/quality-of-life-qol/ 2026-03-31T11:22:13+00:00 https://www.reforms-project.org.uk/glossary/recommended-phase-2-dose-rp2d/ 2026-03-31T11:24:03+00:00 https://www.reforms-project.org.uk/glossary/et-al/ 2026-04-02T08:24:57+00:00 https://www.reforms-project.org.uk/glossary/bd/ 2026-04-02T08:26:03+00:00 https://www.reforms-project.org.uk/glossary/od/ 2026-04-02T08:26:43+00:00 https://www.reforms-project.org.uk/glossary/po/ 2026-04-02T08:27:15+00:00 https://www.reforms-project.org.uk/glossary/aieop/ 2026-04-02T09:14:50+00:00 https://www.reforms-project.org.uk/glossary/anzchog/ 2026-04-02T09:15:32+00:00 https://www.reforms-project.org.uk/glossary/beat-childhood-cancer-research-consortium/ 2026-04-02T09:16:25+00:00 https://www.reforms-project.org.uk/glossary/c17/ 2026-04-02T09:17:25+00:00 https://www.reforms-project.org.uk/glossary/cog/ 2026-04-02T09:18:10+00:00 https://www.reforms-project.org.uk/glossary/epssg/ 2026-04-02T09:18:59+00:00 https://www.reforms-project.org.uk/glossary/itcc/ 2026-04-02T09:20:08+00:00 https://www.reforms-project.org.uk/glossary/sfce/ 2026-04-02T09:20:53+00:00 https://www.reforms-project.org.uk/glossary/confidence-interval-ci/ 2026-04-10T09:17:42+00:00 https://www.reforms-project.org.uk/glossary/hipec/ 2026-05-07T11:40:46+00:00 https://www.reforms-project.org.uk/glossary/antibody-drug-conjugate-adc/ 2026-05-07T11:43:38+00:00 https://www.reforms-project.org.uk/glossary/objective-reponse-rate-orr/ 2026-06-01T16:02:54+00:00